July 9, 2021
Otsuka Pharmaceutical said on July 8 that it has submitted an application seeking approval in Japan for an auto-injector dosage form of its antibody migraine drug Ajovy (fremanezumab). In Japan, Ajovy Subcutaneous Injection 225 mg Syringe was approved in June...read more